Global Etravirine Market Size, Status and Forecast 2024-2031

Report ID: 917516 | Published Date: Sep 2024 | No. of Page: 89 | Base Year: 2023 | Rating: 3.9 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Etravirine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 25 mg Tablets
        1.2.3 100 mg Tablets
        1.2.4 200 mg Tablets
    1.3 Market by Application
        1.3.1 Global Etravirine Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Adults
        1.3.3 Pediatric patients
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Etravirine Market Perspective (2016-2027)
    2.2 Etravirine Growth Trends by Regions
        2.2.1 Etravirine Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Etravirine Historic Market Share by Regions (2016-2021)
        2.2.3 Etravirine Forecasted Market Size by Regions (2022-2027)
    2.3 Etravirine Industry Dynamic
        2.3.1 Etravirine Market Trends
        2.3.2 Etravirine Market Drivers
        2.3.3 Etravirine Market Challenges
        2.3.4 Etravirine Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Etravirine Players by Revenue
        3.1.1 Global Top Etravirine Players by Revenue (2016-2021)
        3.1.2 Global Etravirine Revenue Market Share by Players (2016-2021)
    3.2 Global Etravirine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Etravirine Revenue
    3.4 Global Etravirine Market Concentration Ratio
        3.4.1 Global Etravirine Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Etravirine Revenue in 2020
    3.5 Etravirine Key Players Head office and Area Served
    3.6 Key Players Etravirine Product Solution and Service
    3.7 Date of Enter into Etravirine Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Etravirine Breakdown Data by Type
    4.1 Global Etravirine Historic Market Size by Type (2016-2021)
    4.2 Global Etravirine Forecasted Market Size by Type (2022-2027)

5 Etravirine Breakdown Data by Application
    5.1 Global Etravirine Historic Market Size by Application (2016-2021)
    5.2 Global Etravirine Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Etravirine Market Size (2016-2027)
    6.2 North America Etravirine Market Size by Type
        6.2.1 North America Etravirine Market Size by Type (2016-2021)
        6.2.2 North America Etravirine Market Size by Type (2022-2027)
        6.2.3 North America Etravirine Market Size by Type (2016-2027)
    6.3 North America Etravirine Market Size by Application
        6.3.1 North America Etravirine Market Size by Application (2016-2021)
        6.3.2 North America Etravirine Market Size by Application (2022-2027)
        6.3.3 North America Etravirine Market Size by Application (2016-2027)
    6.4 North America Etravirine Market Size by Country
        6.4.1 North America Etravirine Market Size by Country (2016-2021)
        6.4.2 North America Etravirine Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Etravirine Market Size (2016-2027)
    7.2 Europe Etravirine Market Size by Type
        7.2.1 Europe Etravirine Market Size by Type (2016-2021)
        7.2.2 Europe Etravirine Market Size by Type (2022-2027)
        7.2.3 Europe Etravirine Market Size by Type (2016-2027)
    7.3 Europe Etravirine Market Size by Application
        7.3.1 Europe Etravirine Market Size by Application (2016-2021)
        7.3.2 Europe Etravirine Market Size by Application (2022-2027)
        7.3.3 Europe Etravirine Market Size by Application (2016-2027)
    7.4 Europe Etravirine Market Size by Country
        7.4.1 Europe Etravirine Market Size by Country (2016-2021)
        7.4.2 Europe Etravirine Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Etravirine Market Size (2016-2027)
    8.2 Asia-Pacific Etravirine Market Size by Type
        8.2.1 Asia-Pacific Etravirine Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Etravirine Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Etravirine Market Size by Type (2016-2027)
    8.3 Asia-Pacific Etravirine Market Size by Application
        8.3.1 Asia-Pacific Etravirine Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Etravirine Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Etravirine Market Size by Application (2016-2027)
    8.4 Asia-Pacific Etravirine Market Size by Region
        8.4.1 Asia-Pacific Etravirine Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Etravirine Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Etravirine Market Size (2016-2027)
    9.2 Latin America Etravirine Market Size by Type
        9.2.1 Latin America Etravirine Market Size by Type (2016-2021)
        9.2.2 Latin America Etravirine Market Size by Type (2022-2027)
        9.2.3 Latin America Etravirine Market Size by Type (2016-2027)
    9.3 Latin America Etravirine Market Size by Application
        9.3.1 Latin America Etravirine Market Size by Application (2016-2021)
        9.3.2 Latin America Etravirine Market Size by Application (2022-2027)
        9.3.3 Latin America Etravirine Market Size by Application (2016-2027)
    9.4 Latin America Etravirine Market Size by Country
        9.4.1 Latin America Etravirine Market Size by Country (2016-2021)
        9.4.2 Latin America Etravirine Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Etravirine Market Size (2016-2027)
    10.2 Middle East & Africa Etravirine Market Size by Type
        10.2.1 Middle East & Africa Etravirine Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Etravirine Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Etravirine Market Size by Type (2016-2027)
    10.3 Middle East & Africa Etravirine Market Size by Application
        10.3.1 Middle East & Africa Etravirine Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Etravirine Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Etravirine Market Size by Application (2016-2027)
    10.4 Middle East & Africa Etravirine Market Size by Country
        10.4.1 Middle East & Africa Etravirine Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Etravirine Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Janssen Therapeutics
        11.1.1 Janssen Therapeutics Company Details
        11.1.2 Janssen Therapeutics Business Overview
        11.1.3 Janssen Therapeutics Etravirine Introduction
        11.1.4 Janssen Therapeutics Revenue in Etravirine Business (2016-2021)
        11.1.5 Janssen Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Etravirine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of 25 mg Tablets
    Table 3. Key Players of 100 mg Tablets
    Table 4. Key Players of 200 mg Tablets
    Table 5. Global Etravirine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Etravirine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Etravirine Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Etravirine Market Share by Regions (2016-2021)
    Table 9. Global Etravirine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Etravirine Market Share by Regions (2022-2027)
    Table 11. Etravirine Market Trends
    Table 12. Etravirine Market Drivers
    Table 13. Etravirine Market Challenges
    Table 14. Etravirine Market Restraints
    Table 15. Global Etravirine Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Etravirine Market Share by Players (2016-2021)
    Table 17. Global Top Etravirine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Etravirine as of 2020)
    Table 18. Ranking of Global Top Etravirine Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Etravirine Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Etravirine Product Solution and Service
    Table 22. Date of Enter into Etravirine Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Etravirine Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Etravirine Revenue Market Share by Type (2016-2021)
    Table 26. Global Etravirine Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Etravirine Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Etravirine Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Etravirine Revenue Market Share by Application (2016-2021)
    Table 30. Global Etravirine Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Etravirine Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Etravirine Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Etravirine Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Etravirine Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Etravirine Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Etravirine Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Etravirine Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Etravirine Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Etravirine Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Etravirine Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Etravirine Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Etravirine Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Etravirine Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Etravirine Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Etravirine Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Etravirine Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Etravirine Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Etravirine Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Etravirine Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Etravirine Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Etravirine Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Etravirine Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Etravirine Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Etravirine Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Etravirine Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Etravirine Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Etravirine Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Etravirine Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Etravirine Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Etravirine Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Etravirine Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Janssen Therapeutics Company Details
    Table 63. Janssen Therapeutics Business Overview
    Table 64. Janssen Therapeutics Etravirine Product
    Table 65. Janssen Therapeutics Revenue in Etravirine Business (2016-2021) & (US$ Million)
    Table 66. Janssen Therapeutics Recent Development
    Table 67. Research Programs/Design for This Report
    Table 68. Key Data Information from Secondary Sources
    Table 69. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Etravirine Market Share by Type: 2020 VS 2027
    Figure 2. 25 mg Tablets Features
    Figure 3. 100 mg Tablets Features
    Figure 4. 200 mg Tablets Features
    Figure 5. Global Etravirine Market Share by Application: 2020 VS 2027
    Figure 6. Adults Case Studies
    Figure 7. Pediatric patients Case Studies
    Figure 8. Etravirine Report Years Considered
    Figure 9. Global Etravirine Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Etravirine Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Etravirine Market Share by Regions: 2020 VS 2027
    Figure 12. Global Etravirine Market Share by Regions (2022-2027)
    Figure 13. Global Etravirine Market Share by Players in 2020
    Figure 14. Global Top Etravirine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Etravirine as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Etravirine Revenue in 2020
    Figure 16. Global Etravirine Revenue Market Share by Type (2016-2021)
    Figure 17. Global Etravirine Revenue Market Share by Type (2022-2027)
    Figure 18. North America Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Etravirine Market Share by Type (2016-2027)
    Figure 20. North America Etravirine Market Share by Application (2016-2027)
    Figure 21. North America Etravirine Market Share by Country (2016-2027)
    Figure 22. United States Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Etravirine Market Share by Type (2016-2027)
    Figure 26. Europe Etravirine Market Share by Application (2016-2027)
    Figure 27. Europe Etravirine Market Share by Country (2016-2027)
    Figure 28. Germany Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Etravirine Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Etravirine Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Etravirine Market Share by Region (2016-2027)
    Figure 38. China Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Etravirine Market Share by Type (2016-2027)
    Figure 46. Latin America Etravirine Market Share by Application (2016-2027)
    Figure 47. Latin America Etravirine Market Share by Country (2016-2027)
    Figure 48. Mexico Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Etravirine Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Etravirine Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Etravirine Market Share by Country (2016-2027)
    Figure 54. Turkey Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Etravirine Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Janssen Therapeutics Revenue Growth Rate in Etravirine Business (2016-2021)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
    Figure 60. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Janssen Therapeutics
Frequently Asked Questions
Etravirine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Etravirine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Etravirine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Lacosamide

Lacosamide (INN, formerly known as erlosamide, harkeroside, SPM 927, or ADD 234037), is a medicat ... Read More

Entereg (alvimopan)

Entereg (alvimopan) is the first and only FDA-approved agent indicated to accelerate the time to  ... Read More

Granisetron

Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vo ... Read More

Plerixafor

Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoieti ... Read More